Kousaku Ohinata
Keine laufenden Positionen mehr
Profil
Kousaku Ohinata is the founder of Digestome Therapeutics, Inc. which was founded in 2018.
Ehemalige bekannte Positionen von Kousaku Ohinata
| Unternehmen | Position | Ende |
|---|---|---|
Digestome Therapeutics, Inc.
 Digestome Therapeutics, Inc. Medical/Nursing ServicesHealth Services Digestome Therapeutics, Inc. is a company that focuses on developing sar-optimized drug candidates for various conditions such as depression, anxiety, inflammatory disease, and tinnitus. The company is based in San Francisco, CA. The company's drug candidates are gut-acting and gut-restricted, which provides a safer profile compared to most approved psychiatric drugs. The company was founded in 2018 by Kousaku Ohinata, and the CEO is Kenneth Nicholas Horne. | Gründer | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Digestome Therapeutics, Inc.
Digestome Therapeutics, Inc. Medical/Nursing ServicesHealth Services Digestome Therapeutics, Inc. is a company that focuses on developing sar-optimized drug candidates for various conditions such as depression, anxiety, inflammatory disease, and tinnitus. The company is based in San Francisco, CA. The company's drug candidates are gut-acting and gut-restricted, which provides a safer profile compared to most approved psychiatric drugs. The company was founded in 2018 by Kousaku Ohinata, and the CEO is Kenneth Nicholas Horne. | Health Services |
